Available datasets

	Organism	Individuals	Samples	Mutations	Copy number	Gene expression	Protein expression	Methylation	Gene knock-outs	Matabolites
Fresh frozen lung tumor tissue from patients diagnosed with NSCLC	human		327			218
UTSW lung cancer panel, v.2	human		69			69
Expression data for non-small-cell lung cancer	human		176			176
Fresh frozen lung tumor tissue of NSCLC patients	human		359	359		196
Expression profiles in 117 patients with lung adenocarcinomas	human		117	117		117
Stage I-II lung adenocarcinomas	human		246			246
Immune signatures in longitudinal tumor samples	human		70	54		54
Mutational landscape determines sensitivity to PD-1 blockade	human		34	34
214 melanoma tumor biopsies from a population-based cohort	human
recMAGE A3 antigen-specific cancer immunotherapy in metastatic melanoma and non-small-cell lung cancer: 65 patients	human
Immune checkpoint blockade in melanoma and non-small cell lung cancer patients: 109 RNASeq samples (58 on-treatment and 51 pre-treatment) from 65 patients	human
Genetic basis for clinical response to CTLA-4 blockade	human		64	64
Genomic correlates of response to CTLA-4 blockade	human		110	110
TISMO: syngeneic mouse tumor, in vivo samples	mouse					1518
TISMO: syngeneic mouse tumor, in vitro samples	mouse					605
GL261 tumor endothelial cells from wild type and Eltd1-/- mice	mouse					11
Glioma escape signature and clonal development under immune pressure	mouse					18
Acquired resistance to targeted therapy…	mouse					218
Treatment with the SUMO activating enzyme inhibitors	mouse					24
Syngeneic models for immunotherapeutic drug discovery	mouse					283
Mouse hepatocellular carcinoma cell lines	mouse					24
Prolactin Prevents Hepatocellular Carcinoma by Restricting Innate Immune Activation of c-Myc in Mice	mouse					20
Cancer Cell Line Encyclopedia (CCLE)	human			1616	1613	1377	898	1026	1031	928
Metastatic Melanoma (MSK, JCO Precis Oncol 2017)	human	66	66	66	65
Melanomas (TCGA, Cell 2015)	human	357	359	346
Melanoma (MSK, NEJM 2014)	human	64	64	64	70	20
Metastatic Melanoma (DFCI, Science 2015)	human	110	110	110	117
Melanoma (Broad/Dana Farber, Nature 2012)	human	25	26	25
Metastatic Prostate Adenocarcinoma (SU2C/PCF Dream Team, PNAS 2019)	human	429	444	444	449	327
Metastatic Prostate Cancer (SU2C/PCF Dream Team, Cell 2015)	human	150	150	150	156	117
Metastatic Prostate Adenocarcinoma (MCTP, Nature 2012)	human	119	121	61	66	93
Metastatic castration-sensitive prostate cancer (MSK, Clin Cancer Res 2020)	human	424	424	399	429
Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)	human	491	489	316	6	489		490
Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	human	585	585	409	578	300	414	587
Ovarian Serous Cystadenocarcinoma (TCGA, Firehose Legacy)	human	587	617	316	585	597	436	0
Nerve Sheath Tumors (Johns Hopkins, Sci Data 2020)	human	18	19	19
Non-Small Cell Lung Cancer (University of Turin, Lung Cancer 2017)	human		41	41
Non-Small Cell Lung Cancer (TRACERx, NEJM & Nature 2017)	human	100	447	447
Non-Small Cell Lung Cancer (MSK, J Clin Oncol 2018)	human	240	240	240	245
Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018)	human	75	75	75
Non-Small Cell Lung Cancer (MSK, Science 2015)	human	16	16	16
Metastatic Non-Small Cell Lung Cancer (MSK, Nature Medicine 2022)	human	1127	2621	1972	1262
Nasopharyngeal Carcinoma (Singapore, Nat Genet 2014)	human	56	56	56
Non-Hodgkin Lymphoma (BCGSC, Nature 2011)	human	14	14	14
Neuroendocrine Prostate Cancer (Multi-Institute, Nat Med 2016)	human	81	114	114	6
Neuroblastoma (Broad, Nature 2015)	human	56	56	56
Neuroblastoma (Broad, Nat Genet 2013)	human	240	240	238
Neuroblastoma (AMC Amsterdam, Nature 2012)	human	87	87	73
Ovarian Cancer – MSK SPECTRUM (MSK, Nature 2022)	human	42	82	81	87
MSK MetTropism (MSK, Cell 2021)	human	25775	25775	24755	25780
MSK-IMPACT Clinical Sequencing Cohort (MSK, Nat Med 2017)	human	10336	10945	10129	10950
MSK-IMPACT and MSK-ACCESS Mixed Cohort (MSK, Nat Commun 2021)	human	617	1446	1187	1451
Malignant Peripheral Nerve Sheath Tumor (MSK, Nat Genet 2014)	human	15	15	15	15
Myeloproliferative Neoplasms (CIMR, NEJM 2013)	human		151	150
Meningioma (University of Toronto, Nature 2021)	human		121	115	120	120	96	121
Multiple Myeloma (Broad, Cancer Cell 2014)	human	211	211	205
Mixed Tumors Selpercatinib RET Trial (MSK, Nat Commun. 2022)	human	72	188	158	59
Mixed cfDNA (MSK, Genome Med 2021)	human	118	229	204	234
MSS Mixed Solid Tumors (Broad/Dana-Farber, Nat Genet 2018)	human	249	249	249	6
Metastatic Solid Cancers (UMich, Nature 2017)	human	500	500	500	6
Mesothelioma (TCGA, PanCancer Atlas)	human	87	87	82	93	87	63	90
Mesothelioma (TCGA, Firehose Legacy)	human	87	87	83	93	87	63	88
Metastatic Melanoma (UCLA, Cell 2016)	human	38	38	37	43	26
Melanoma (MSK, Clin Cancer Res 2021)	human	696	696	692	701
Metastatic Melanoma (DFCI, Nature Medicine 2019)	human	144	144	144	144
Myelodysplasia (UTokyo, Nature 2011)	human	29	29	28
Myelodysplastic (MSK, 2020)	human		4231	4231
Myelodysplastic Syndromes (MDS IWG, IPSSM, NEJM Evidence 2022)	human	3323	3323	3227
Mantle Cell Lymphoma (IDIBIPS, PNAS 2013)	human		29	29
Mature B-cell malignancies (MD Anderson Cancer Center)	human	759	760	755	6	290
Medulloblastoma (Sickkids, Nature 2016)	human	46	46	44
Medulloblastoma (PCGP, Nature 2012)	human	37	37	37
Medulloblastoma (ICGC, Nature 2012)	human	125	125	114
Medulloblastoma (DKFZ, Nature 2017)	human	491	491	441
Medulloblastoma (Broad, Nature 2012)	human		92	92
Metaplastic Breast Cancer (MSK,NPJ Breast Cancer 2021)	human	19	19	19
Lymphoma Cell Lines (MSK, Blood 2020)	human	34	34	34	39
Lung Squamous Cell Carcinoma (TCGA, Nature 2012)	human	178	178	178	185	121		105
Lung Squamous Cell Carcinoma (TCGA, PanCancer Atlas)	human	487	487	469	493	484	317	489
Lung Squamous Cell Carcinoma (TCGA, Firehose Legacy)	human	504	511	178	507	504	328	504
Lung Squamous Cell Carcinoma (CPTAC, Cell 2021)	human	108	108	108		108	110	0
Lung Cancer (SMC, Cancer Research 2016)	human	6	22	22
Lung Cancer in Never Smokers (NCI, Nature Genetics 2021)	human	232	232	231
Lung Adenocarcinoma (MSK Mind,Nature Cancer 2022)	human	247	247	242	252
Non-Small Cell Cancer (MSK, Cancer Discov 2017)	human	860	915	886	920
Lung Adenocarcinoma (TSP, Nature 2008)	human		163	163
Lung Adenocarcinoma (TCGA, Nature 2014)	human	223	230	230	236	230	181	230
Lung Adenocarcinoma (TCGA, PanCancer Atlas)	human	566	566	562	517	510	360	565
Lung Adenocarcinoma (TCGA, Firehose Legacy)	human			230	523	32	365	581
Lung Adenocarcinoma (OncoSG, Nat Genet 2020)	human	305	305	302	308	169
Lung Adenocarcinoma (MSK, 2021)	human	93	186	186	191
Lung Adenocarcinoma (MSK, J Thorac Oncol 2020)	human	604	604	598	609
Lung Adenocarcinoma (MSK, Science 2015)	human	35	35	34	6
Lung Adenocarcinoma (MSK, NPJ Precision Oncology 2021)	human	426	426	419	431
Lung Adenocarcinoma (CPTAC, Cell 2020)	human	110	110	109	109	110	113	0
Lung Adenocarcinoma (Broad, Cell 2012)	human	183	183	183	181
Liver Hepatocellular Carcinoma (TCGA, PanCancer Atlas)	human	372	372	358	373	366	179	375
Liver Hepatocellular Carcinoma (TCGA, Firehose Legacy)	human	377	379	373	376	373		380
Liver Hepatocellular Carcinoma (RIKEN, Nat Genet 2012)	human	25	27	21
Liver Hepatocellular Carcinoma (AMC, Hepatology 2014)	human	231	231	231	232
Low-Grade Serous Ovarian Cancer (MSK, Clin Cancer Res 2022)	human		119	94
Merged Cohort of LGG and GBM (TCGA, Cell 2016)	human	1122	1122	812	1084
Low-Grade Gliomas (UCSF, Science 2014)	human	23	61	61
Kidney Renal Papillary Cell Carcinoma (TCGA, PanCancer Atlas)	human	283	283	274	289	283	209	286
Kidney Renal Papillary Cell Carcinoma (TCGA, Firehose Legacy)	human	291	293	282	294	291	216	293
Kidney Renal Clear Cell Carcinoma (TCGA, Nature 2013)	human	446	446	424	442	426	411	193
Kidney Renal Clear Cell Carcinoma (TCGA, PanCancer Atlas)	human	512	512	356	515	510	455	514
Kidney Renal Clear Cell Carcinoma (TCGA, Firehose Legacy)	human	537	538	451	534	535	478	537
Kidney Renal Clear Cell Carcinoma (BGI, Nat Genet 2012)	human	98	98	81
Kidney Chromophobe (TCGA, Cancer Cell 2014)	human	66	66	65	73			67
Kidney Chromophobe (TCGA, PanCancer Atlas)	human	65	65	65	71	65	62	68
Kidney Chromophobe (TCGA, Firehose Legacy)	human	113	113	66	72	66	63	67
Intrahepatic Cholangiocarcinoma (Shanghai, Nat Commun 2014)	human	103	103	103
Oral Squamous Cell Carcinoma (MD Anderson, Cancer Discov 2013)	human	40	40	40
Liver Hepatocellular Adenoma and Carcinomas (MSK, PLOS One 2018)	human		19	17	25
Metastatic Esophagogastric Cancer (MSK, Cancer Discovery 2017)	human	305	341	337	346
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma (TCGA, Firehose Legacy)	human	48	48	48	54	48	33	49
Metastatic Colorectal Cancer (MSK, Cancer Cell 2018)	human	1099	1134	1133	1139
Mixed cfDNA (MSK, Nature Medicine 2019)	human	124	248	248
NCI-60 Cell Lines (NCI, Cancer Res 2012)	human	67	67	60	66	60
Kidney Renal Clear Cell Carcinoma (IRC, Nat Genet 2014)	human	10	79	78
Metastatic Breast Cancer (MSK, Cancer Discovery 2022)	human	1116	1365	1305	1370
MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)	human	145	145	140	150
Juvenile Papillomatosis and Breast Cancer (MSK,J Pathol. 2015)	human		5	5	6
Metastatic Breast Cancer (INSERM, PLoS Med 2016)	human	216	216	213	216
Nonmuscle Invasive Bladder Cancer (MSK Eur Urol 2017)	human	105	105	103	110
Metastatic Biliary Tract Cancers (SUMMIT – Neratinib Basket Trial, 2022)	human	25	36	34	33
Upper Tract Urothelial Carcinoma PDX (MSK, Nat Commun 2020)	human	34	78	74	82
Pancreatic Ductal Adenocarcinoma (CPTAC, Cell 2021)	human	140	140	140	5	140	140	0
Glioblastoma (CPTAC, Cell 2021)	human	99	99	99	102	98	102	0
Pediatric Wilms’ Tumor (TARGET, 2018)	human	652	657	102	135	132		127
Squamous Cell Carcinoma of the Vulva (CUK, Exp Mol Med 2018)	human	15	15	15
Uveal Melanoma (TCGA, Firehose Legacy)	human			80	87			81
Uveal Melanoma (TCGA, PanCancer Atlas)	human	80	80	80	87	80	12	83
Upper Tract Urothelial Cancer (MSK, Eur Urol 2015)	human	83	85	84	91
Upper Tract Urothelial Carcinoma (MSK, Nat Commun 2020)	human	119	119	115	124
Upper Tract Urothelial Carcinoma (IGBMC, Genome Biology 2021)	human		30	30
Upper Tract Urothelial Carcinoma (Cornell/Baylor/MDACC, Nat Commun 2019)	human	47	47	37
Uterine Sarcoma/Mesenchymal (MSK, Clin Cancer Res 2020)	human	107	108	92	113
Unclassified Renal Cell Carcinoma (MSK, Nature 2016)	human	62	62	53	68
Uveal Melanoma (QIMR, Oncotarget 2016)	human	28	28	25
Uterine Carcinosarcoma (TCGA, Firehose Legacy)	human			57	63		48	58
Uterine Carcinosarcoma (TCGA, PanCancer Atlas)	human	57	57	57	63	57	48	60
Uterine Carcinosarcoma (Johns Hopkins, Nat Commun 2014)	human	22	22	22
Uterine Corpus Endometrial Carcinoma (TCGA, Firehose Legacy)	human	548	549	248	545	229	440	549
Uterine Corpus Endometrial Carcinoma (TCGA, Nature 2013)	human	373	373	248	370	54	200	118
Uterine Corpus Endometrial Carcinoma (TCGA, PanCancer Atlas)	human	529	529	515	530	527	423	532
Endometrial Cancer (MSK, 2018)	human	189	197	195	202
Endometrial Carcinoma (CPTAC, Cell 2020)	human	95	95	95	95	95	95	92
Endometrial Carcinoma MSI (MSK, Clin Cancer Res 2022)	human		181	181
Endometrial Carcinoma cfDNA (MSK, Clin Cancer Res 2022)	human		44	42
Uterine Clear Cell Carcinoma (NIH, Cancer 2017)	human	16	16	16
TMB and Immunotherapy (MSK, Nat Genet 2019)	human	1661	1661	1610
Poorly-Differentiated and Anaplastic Thyroid Cancers (MSK, JCI 2016)	human	117	117	112	122
Thymoma (TCGA, Firehose Legacy)	human	124	124	123	129	120	90	125
Thymoma (TCGA, PanCancer Atlas)	human	123	123	123	130	119	90	126
Thyroid Carcinoma (TCGA, Firehose Legacy)	human			405	506		224	512
Papillary Thyroid Carcinoma (TCGA, Cell 2014)	human	496	496	401	500	482	222	497
Thyroid Carcinoma (TCGA, PanCancer Atlas)	human	499	500	485	504	498	369	503
Testicular Germ Cell Cancer (TCGA, Firehose Legacy)	human			155	157		122	157
Testicular Germ Cell Tumors (TCGA, PanCancer Atlas)	human	149	149	144	156	149	118	152
Thymic Epithelial Tumors (NCI, Nat Genet 2014)	human	31	32	28
SUMMIT – Neratinib Basket Study (Multi-Institute, Nature 2018)	human	141	141	106	105
Esophageal Carcinoma (TCGA, Nature 2017)	human	559	559	518	384
Stomach Adenocarcinoma (U Tokyo, Nat Genet 2014)	human	30	30	30
Stomach Adenocarcinoma (UHK, Nat Genet 2011)	human	22	22	22
Stomach Adenocarcinoma (TCGA, Firehose Legacy)	human	443	478	395	447	415	392	444
Stomach Adenocarcinoma (TCGA, Nature 2014)	human	295	295	289	299	265
Stomach Adenocarcinoma (TCGA, PanCancer Atlas)	human	440	440	436	445	412	354	443
Stomach Adenocarcinoma (Pfizer and UHK, Nat Genet 2014)	human	100	100	100
Gastric Cancer (OncoSG, 2018)	human	147	147	147	108	11
Skin Cutaneous Melanoma (Yale, Nat Genet 2012)	human	147	147	91
Skin Cutaneous Melanoma (TCGA, Firehose Legacy)	human	470	480	368	373	472	355	474
Skin Cutaneous Melanoma (TCGA, PanCancer Atlas)	human	442	448	440	374	443	329	446
Skin Cutaneous Melanoma (Broad, Cell 2012)	human	121	121	121
Skin Cutaneous Melanoma(Broad, Cancer Discov 2014)	human	46	78	78
Small Cell Lung Cancer (U Cologne, Nature 2015)	human	120	120	110		81
Small Cell Lung Cancer (Johns Hopkins, Nat Genet 2012)	human	80	80	42
Small Cell Lung Cancer (CLCGP, Nat Genet 2012)	human	29	29	29
Small-Cell Lung Cancer (Multi-Institute, Cancer Cell 2017)	human		20	20	6
Small Cell Carcinoma of the Ovary (MSK, Nat Genet 2014)	human	12	12	11
Sarcoma (MSK, Nat Commun. 2022)	human	2138	2138	1659	2143
Sarcoma (TCGA, Firehose Legacy)	human	261	265	247	263	263	226	266
Adult Soft Tissue Sarcomas (TCGA, Cell 2017)	human	206	206	206	213
Sarcoma (TCGA, PanCancer Atlas)	human	255	255	234	259	253	218	258
Sarcoma (MSKCC/Broad, Nat Genet 2010)	human		207	35	212	149
Pediatric Rhabdoid Tumor (TARGET, 2018)	human	72	72	34		43
Rhabdomyosarcoma (NIH, Cancer Discov 2014)	human	43	43	53
Rectal Cancer (MSK, Nature Medicine 2022)	human	738	801	787	697	112
Rectal Cancer (MSK,Nature Medicine 2019)	human	301	339	334	344
Retinoblastoma (MSK, Cancers 2021)	human	81	83	67	88
Retinoblastoma cfDNA (MSK, Cancer Med 2020)	human		14	14
Prostate Cancer Brain Metastases (Bern, Nat Commun. 2022)	human	51	168	168
Prostate Cancer (DKFZ, Cancer Cell 2018)	human	292	324	313		118
Prostate Adenocarcinoma (TCGA, Firehose Legacy)	human	500	501	499	498	498	352	500
Prostate Adenocarcinoma (TCGA, Cell 2015)	human	333	334	333	339	333	146	334
Prostate Adenocarcinoma (TCGA, PanCancer Atlas)	human	494	494	493	495	493	350	497
Prostate Adenocarcinoma (MSK, Clin Cancer Res. 2022)	human	1417	1417	1365	1422
Prostate Adenocarcinoma (MSK/DFCI, Nature Genetics 2018)	human	1013	1013	1012	1019
Prostate Adenocarcinoma (MSK, Cancer Cell 2010)	human	238	240	61	211	155
Prostate Adenocarcinoma Organoids (MSK, Cell 2014)	human	7	12	11	6	9
Prostate Cancer (MSK, JCO Precis Oncol 2017)	human	451	504	452	507
Prostate Adenocarcinoma (MSK, PNAS 2014)	human	104	104		109
Race Differences in Prostate Cancer (MSK, 2021)	human	2069	2069	1831	2074
Prostate Cancer (MSK, Cell Metab 2020)	human	10	18	14	23
Prostate Adenocarcinoma (Fred Hutchinson CRC, Nat Med 2016)	human	63	176	141	156	171
Prostate Adenocarcinoma (SMMU, Eur Urol 2017)	human	65	65	65	71	65
Prostate Adenocarcinoma (CPC-GENE, Nature 2017)	human	477	477	449
Prostate Adenocarcinoma (MSK, Eur Urol 2020)	human	1465	1465	1289	1470
Prostate Adenocarcinoma (Broad/Cornell, Nat Genet 2012)	human	123	123	112	115	30
Prostate Adenocarcinoma (Broad/Cornell, Cell 2013)	human	82	82	57	63
Pediatric Preclinical Testing Consortium (CHOP, Cell Rep 2019)	human	244	261	240	258	244
Pleural Mesothelioma (NYU, Cancer Res 2015)	human	22	22	22
Pediatric Pan-Cancer (DKFZ, Nature 2017)	human	961	961	876	6
Pheochromocytoma and Paraganglioma (TCGA, Firehose Legacy)	human			184	169		82	185
Pheochromocytoma and Paraganglioma (TCGA, Cell 2017)	human	173	178	178		173	76	179
Pheochromocytoma and Paraganglioma (TCGA, PanCancer Atlas)	human	178	178	178	167	178	79	181
Primary Central Nervous System Lymphoma (Mayo Clinic, Clin Cancer Res 2015)	human	19	19	10
Pilocytic Astrocytoma (ICGC, Nature Genetics 2013)	human	96	96	78
Insulinoma (Shanghai, Nat Commun 2013)	human	10	10	10
Pancreatic Neuroendocrine Tumors (Johns Hopkins University, Science 2011)	human	10	10	10
Pancreatic Neuroendocrine Tumors (Multi-Institute, Nature 2017)	human	98	98	98
Pan-cancer analysis of whole genomes (ICGC/TCGA, Nature 2020)	human	2583	2922	2683	2702	1209
China Pan-cancer (OrigiMed, Nature 2022)	human	10194	10194	0	10194
Cystic Tumor of the Pancreas (Johns Hopkins, PNAS 2011)	human	32	32	32
Pancreatic Cancer (UTSW, Nat Commun 2015)	human	109	109	109	116
Pancreatic Adenocarcinoma (TCGA, Firehose Legacy)	human	185	186	150	190	179	123	186
Pancreatic Adenocarcinoma (TCGA, PanCancer Atlas)	human	184	184	176	189	177	122	186
Pancreatic Adenocarcinoma (QCMG, Nature 2016)	human	456	456	383
Pancreatic Adenocarcinoma (ICGC, Nature 2012)	human	99	99	99
Acinar Cell Carcinoma of the Pancreas (JHU, J Pathol 2014)	human	23	23	23
Anaplastic Oligodendroglioma and Anaplastic Oligoastrocytoma (MSK, Neuro Oncol 2017)	human	19	22	22	27
Tumors with TRK fusions (MSK, Clin Cancer Res 2020)	human	76	106	43	59
Pan-Lung Cancer (TCGA, Nat Genet 2016)	human	1144	1144	1144	1150
Diffuse Large B-cell Lymphoma (BCGSC, Blood 2013)	human	53	53	52
Renal Non-Clear Cell Carcinoma (Genentech, Nat Genet 2014)	human	145	146	139
Pediatric Neuroblastoma (TARGET, 2018)	human	1076	1089	352	65	357
Cancer Therapy and Clonal Hematopoiesis (MSK, Clin Cancer Res 2022)	human	657	657	31
Cancer Therapy and Clonal Hematopoiesis (MSK, Nat Genet 2020)	human	24146	24146	7216
Rhabdoid Cancer (BCGSC, Cancer Cell 2016)	human	40	40	40
The Metastatic Prostate Cancer Project (Provisional, June 2021)	human	97	123	82	87
Acute myeloid leukemia or myelodysplastic syndromes (WashU, 2016)	human	116	136	99
Pediatric Pan-cancer (Columbia U, Genome Med 2016)	human	89	103	99
RAD51B Associated Mixed Cancers (Mandelker 2021)	human		19	19	6
Pediatric Pancan Tumors (MSK,Nat Commun. 2022)	human	134	135	106	102
Pan-Cancer MSK-IMPACT MET Validation Cohort (MSK 2022)	human	69	69	67	74
Acral Melanoma (TGEN, Genome Res 2017)	human	34	38	37	38	35
Thoracic Cancer (MSK, Nat Commun 2021)	human	39	69	68	74
Thoracic PDX (MSK, Provisional)	human	172	318	305	316
Hepatocellular Adenoma (INSERM, Cancer Cell 2014)	human	30	46	46
Brain Lower Grade Glioma (TCGA, Firehose Legacy)	human	515	530	286	519	530	435	531
Brain Lower Grade Glioma (TCGA, PanCancer Atlas)	human	514	514	510	517	514	428	517
Chronic Lymphocytic Leukemia (Broad, Cell 2013)	human		160	159
Acute Myeloid Leukemia (TCGA, Firehose Legacy)	human	200	200	197	197	179		195
Acute Myeloid Leukemia (TCGA, NEJM 2013)	human	200	200	196	197	173		195
Acute Myeloid Leukemia (TCGA, PanCancer Atlas)	human	200	200	199	197	173		194
Intrahepatic Cholangiocarcinoma (MSK, Clin Cancer Res 2021)	human		219	199	94
Intrahepatic Cholangiocarcinoma (MSK, Hepatology 2021)	human	412	412	379	417
Intrahepatic Cholangiocarcinoma (Mount Sinai 2015)	human	8	8	8
Head and Neck Squamous Cell Carcinoma (TCGA, Firehose Legacy)	human			512	529		212	531
Head and Neck Squamous Cell Carcinoma (TCGA, Nature 2015)	human	279	279	279	285	279	200	280
Head and Neck Squamous Cell Carcinoma (TCGA, PanCancer Atlas)	human	523	523	502	523	515	211	526
Head and Neck Squamous Cell Carcinoma (Johns Hopkins, Science 2011)	human	32	32	32
Head and Neck Squamous Cell Carcinoma (Broad, Science 2011)	human	74	74	74
Recurrent and Metastatic Head & Neck Cancer (MSK, JAMA Oncol 2016)	human	151	151	132	156
Histiocytosis Cobimetinib (MSK, Nature 2019)	human	18	52	24	38
High-Grade Serous Ovarian Cancer (MSK, NPJ Genome Med 2021)	human	45	45	45	50
Combined Hepatocellular and Intrahepatic Cholangiocarcinoma (Peking University, Cancer Cell 2019)	human	121	173	173
Hepatocellular Carcinoma (MSK, Clin Cancer Res 2018)	human	127	127	121	132
Hepatocellular Carcinoma (MERiC/Basel, Nat Commun. 2022)	human	114	122	122
Hepatocellular Carcinomas (INSERM, Nat Genet 2015)	human	243	243	243
Glioma (MSK, Clin Cancer Res 2019)	human	923	1004	991	911
Glioma (MSK, Nature 2019)	human	42	91	90	96
Gastrointestinal Stromal Tumor (MSK, NPJ Precis Oncol 2023)	human	499	669	637	674
Germ Cell Tumors and Shared Leukemias (MSK, J Clin Invest 2020)	human	11	21	21	6
Germ Cell Tumors (MSK, J Clin Oncol 2016)	human	180	180	125	185
Glioblastoma Multiforme (TCGA, Firehose Legacy)	human	596	619	290	583	548	244	434
Glioblastoma (TCGA, Cell 2013)	human	577	577	291	529	152	193
Glioblastoma (TCGA, Nature 2008)	human	206	206	83	209	206		59
Glioblastoma Multiforme (TCGA, PanCancer Atlas)	human	585	592	395	581	160	231	425
Brain Tumor PDXs (Mayo Clinic, Clin Cancer Res 2020)	human	95	97	83	82	65		74
Glioblastoma (Columbia, Nat Med. 2019)	human	42	42	15
Gallbladder Carcinoma (Shanghai, Nat Genet 2014)	human	32	32	32
Gallbladder Cancer (MSK, 2022)	human	233	244	237	249
Gallbladder Cancer (MSK, Cancer 2018)	human	101	103	97	108
Esophageal Squamous Cell Carcinoma (UCLA, Nat Genet 2014)	human	139	139	137
Esophageal Squamous Cell Carcinoma (ICGC, Nature 2014)	human	88	88	88
Esophageal Carcinoma (TCGA, Firehose Legacy)	human	185	186	185	190	185	126	187
Esophageal Adenocarcinoma (TCGA, PanCancer Atlas)	human	182	182	182	188	181	125	185
Esophageal Adenocarcinoma (DFCI, Nat Genet 2013)	human	151	151	146
Ewing Sarcoma (Institut Curie, Cancer Discov 2014)	human	112	115	112	6
Pediatric Ewing Sarcoma (DFCI, Cancer Discov 2014)	human	103	107	105
Esophageal Cancer-TRAP Project (MSK, Lancet Oncol 2020)	human	37	68	62	68
Gastric Adenocarcinoma (TMUCIH, PNAS 2015)	human	78	78	78
Esophageal/Stomach Cancer (MSK, 2020)	human	487	487	471	492
Esophagogastric Cancer (MSK, Clin Cancer Res 2022)	human	237	237	231	242
Diffuse Large B-Cell Lymphoma (Duke, Cell 2017)	human	1001	1001	972
Diffuse Large B cell Lymphoma (DFCI, Nat Med 2018)	human	135	135	135
Diffuse Large B-Cell Lymphoma (TCGA, PanCancer Atlas)	human	48	48	37	54	48	33	51
Diffuse Large B-Cell Lymphoma (Broad, PNAS 2012)	human		58	58
Diffuse Glioma (GLASS Consortium, Nature 2019)	human	222	444	444	6	78
Desmoplastic Melanoma (Broad Institute, Nat Genet 2015)	human	20	20	20
Cutaneous T Cell Lymphoma (Columbia U, Nat Genet 2015)	human		43	42
Cutaneous Squamous Cell Carcinoma (UCSF, NPJ Genom Med 2021)	human	83	83	83
Cutaneous Squamous Cell Carcinoma (MD Anderson, Clin Cancer Res 2014)	human	39	39	39
Cutaneous Squamous Cell Carcinoma (DFCI, Clin Cancer Res 2015)	human	29	29	29
Disparities in metastatic colorectal cancer between Africans and Americans (MSK, 2020)	human	64	64	64	69
Colorectal Cancer (MSK, JCO Precis Oncol 2022)	human	47	47	47	52
Colorectal Cancer (MSK, Gastroenterology 2020)	human	471	471	467	476
Colorectal Adenocarcinoma (TCGA, Firehose Legacy)	human	629	640	223	622	600	498	397
Colorectal Adenocarcinoma (TCGA, Nature 2012)	human	276	276	224	263	260		237
Colorectal Adenocarcinoma (TCGA, PanCancer Atlas)	human	594	594	528	598	592	464	594
Colorectal Adenocarcinoma Triplets (MSK, Genome Biol 2014)	human	69	138	138
Colorectal Adenocarcinoma (Genentech, Nature 2012)	human	74	74	72
Colorectal Adenocarcinoma (DFCI, Cell Reports 2016)	human	619	619	619
Colon Cancer (CPTAC-2 Prospective, Cell 2019)	human	110	110	106	111	106	97
Colon Adenocarcinoma (CaseCCC, PNAS 2015)	human	29	29	29
Chronic lymphocytic leukemia (ICGC, Nature Genetics 2011)	human		105	105
Chronic Lymphocytic Leukemia (IUOPA, Nature 2015)	human		506	506
Chronic Lymphocytic Leukemia (Broad, Nature 2015)	human	537	537	537		156
Cholangiocarcinoma (TCGA, Firehose Legacy)	human	45	51	35	42	36	30	37
Cholangiocarcinoma (TCGA, PanCancer Atlas)	human	36	36	36	42	36	30	39
Cholangiocarcinoma (National University of Singapore, Nat Genet 2012)	human	8	8	8
Cholangiocarcinoma (National Cancer Centre of Singapore, Nat Genet 2013)	human	15	15	15
Cholangiocarcinoma (MSK, Clin Cancer Res 2018)	human	192	195	182	200
Intrahepatic Cholangiocarcinoma (JHU, Nat Genet 2013)	human		40	40
Cholangiocarcinoma (ICGC, Cancer Discov 2017)	human	489	489	417
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA, Firehose Legacy)	human	307	310	194	301	306	173	310
Cervical Squamous Cell Carcinoma (TCGA, PanCancer Atlas)	human	297	297	281	299	294	166	300
Cancer Cell Line Encyclopedia (Novartis/Broad, Nature 2012)	human	1020	1020	905	1001	967
Renal Clear Cell Carcinoma (UTokyo, Nat Genet 2013)	human	106	106	106
Clear Cell Renal Cell Carcinoma (DFCI, Science 2019)	human	35	35	35
Cancer Cell Line Encyclopedia (Broad, 2019)	human	1461	1739	1570	1035	1155	375
Breast Cancer (MSK, Cancer Cell 2018)	human	1756	1918	1834	1923
Breast Cancer (MSK, Nature Cancer 2020)	human	51	141	130	44
Breast Invasive Carcinoma (TCGA, Firehose Legacy)	human	1097	1108	982	1086	1100	892	789
Breast Invasive Carcinoma (TCGA, Cell 2015)	human	817	818	817	822	817	673	818
Breast Invasive Carcinoma (TCGA, Nature 2012)	human	825	825	33	784	528	408	312
Breast Invasive Carcinoma (TCGA, PanCancer Atlas)	human	1084	1084	1009	1076	1082	876	1069
Breast Cancer (SMC 2018)	human	187	187	185		168
Breast Invasive Carcinoma (Sanger, Nature 2012)	human	100	100	100
Breast Cancer (MSK, Clinical Cancer Res 2020)	human		60	60
Breast Cancer (MSK, NPJ Breast Cancer 2019)	human	68	70	70	75
Breast Cancer (METABRIC, Nature 2012 & Nat Commun 2016)	human	2509	2509	2369	2173	1980		1418
The Metastatic Breast Cancer Project (Archived, 2020)	human	180	237	237	243	146
The Metastatic Breast Cancer Project (Provisional, December 2021)	human	301	379	379	385	157
Breast Cancer (HTAN, 2022)	human	1	5	5	5
Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	human	122	122	122	121	121	126
Breast Invasive Carcinoma (Broad, Nature 2012)	human	103	103	103
Breast Invasive Carcinoma (British Columbia, Nature 2012)	human	65	65	65
Breast Cancer Xenografts (British Columbia, Nature 2015)	human		117	116	6
Pediatric Brain Cancer (CPTAC/CHOP, Cell 2020)	human	199	218	200	190	187	218
Bladder Urothelial Carcinoma (TCGA, Firehose Legacy)	human	412	413	130	414	408	344	414
Bladder Urothelial Carcinoma (TCGA, Nature 2014)	human	131	131	130	134	129	120	132
Bladder Cancer (TCGA, Cell 2017)	human	411	413	412	408	408	344	414
Bladder Urothelial Carcinoma (TCGA, PanCancer Atlas)	human	411	411	409	414	407	343	414
Bladder Cancer (MSK, Nat Genet 2016)	human	31	34	34	38
Bladder Cancer (MSK, Eur Urol 2014)	human	109	109	109	114
Bladder Cancer (MSK, J Clin Onco 2013)	human	97	97	64		57		25
Bladder Cancer (MSK/TCGA, 2020)	human	476	476	472	448	296	243
Bladder Urothelial Carcinoma (DFCI/MSK, Cancer Discov 2014)	human	50	50	50
Urothelial Carcinoma (Cornell/Trento, Nat Gen 2016)	human	32	72	72	53
Bladder Urothelial Carcinoma (BGI, Nat Genet 2013)	human	99	99	99
Urothelial Carcinoma (BCAN/HCRN, 2022)	human	218	203	192
Breast Fibroepithelial Tumors (Duke-NUS, Nat Genet 2015)	human	22	22	22
Basal Cell Carcinoma (UNIGE, Nat Genet 2016)	human		293	292
The Angiosarcoma Project – Count Me In (Nature Medicine, 2020)	human	36	48	48	54
The Angiosarcoma Project (Provisional, July 2020)	human	62	83	83	89
Ampullary Carcinoma (Baylor College of Medicine, Cell Reports 2016)	human	160	160	152
Pediatric Acute Myeloid Leukemia (TARGET, 2018)	human	899	1025	150	246	63		185
Acute Myeloid Leukemia (OHSU, Nature 2018)	human	562	672	608		451
Acute Lymphoblastic Leukemia (St Jude, Nat Genet 2016)	human	69	73	73
Acute Lymphoblastic Leukemia (St Jude, Nat Genet 2015)	human	85	93	37
Hypodiploid Acute Lymphoid Leukemia (St Jude, Nat Genet 2013)	human	40	44	44
Pediatric Acute Lymphoid Leukemia – Phase II (TARGET, 2018)	human	1551	1978	150	770	346		150
Adenoid Cystic Carcinoma (Sanger/MDA, JCI 2013)	human	24	24	24
Adenoid Cystic Carcinoma (MSK, Nat Genet 2013)	human	60	60	59	66
Adenoid Cystic Carcinoma (MGH, Nat Gen 2016)	human		10	10
Adenoid Cystic Carcinoma (MDA, Clin Cancer Res 2015)	human	102	102	21
Adenoid Cystic Carcinoma (JHU, Cancer Prev Res 2016)	human	25	25	25
Adenoid Cystic Carcinoma (FMI, Am J Surg Pathl. 2014)	human	28	28	15	28
Adrenocortical Carcinoma (TCGA, Firehose Legacy)	human	92	92	90	96	79	46	81
Adrenocortical Carcinoma (TCGA, PanCancer Atlas)	human	92	92	91	95	78	45	82
Adenoid Cystic Carcinoma Project (J Clin Invest 2019)	human	1045	1049	1023	933
Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	human	12	12	12	12